Zydus Cadila develops a wide range of healthcare therapies including small molecule drugs and vaccines. Credit: Marco Verch Professional Photographer.

Indian pharmaceutical company Zydus Cadila has introduced new feature in its drug packaging to help fight counterfeit products.

The company has integrated a new IT-enabled scratch code created by Hyperlink Infosystem.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It will be printed under a concealed scratchable surface, which will help customers verify products by entering the code on the pack.

Zydus Verify App connects the code and provides the brand name to authenticate the product. The app is available in both Google Play store and Apple Store.

Zydus Cadila initially plans to implement the technology in its products Remdac (Remdesivir) and Virafin Inj (Pegylated Interpheron Alpha 2b).

Products packs equipped with the new technology will be available starting third week of next month. The company also aims to implement the feature on its other products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Cadila Healthcare (also known as Zydus Cadila) managing director Dr Sharvil Patel said: “The problem of counterfeit drugs undermines the painstaking efforts that are put in to ensure that the end user or patients receive a product that is safe and manufactured with the highest standards of quality excellence.

“Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life threatening in some cases. To curb this menace we looked at a user friendly solution which can reassure the patient that the product is genuine and safe. Zydus Verify is a Tec enabled solution that will safeguard patients against counterfeit drugs.”

Zydus Cadila specialises in developing and marketing a wide range of healthcare therapies, including small molecule drugs, biologic therapeutics and vaccines.